CHS invests in Ontario-based manufacturing
by CM Staff
CHS received $1.9 million from the Government of Ontario through the Ontario Together Fund to help CHS modernize and expand its Oakville plant.
OAKVILLE — Canadian Hospital Specialties Limited has completed the acquisitions of Stadco Polyproducts Inc. and Respan Products Inc.
CHS says these acquisitions will increase its capabilities in injection molding and tubing extrusion.
These newly acquired companies with manufacturing plants located in Mississauga, and Erin, Ont., will be an addition to CHS’ existing Oakville plant which is currently undergoing a $3.8 million facility upgrade.
Earlier in 2022, CHS received $1.9 million from the Government of Ontario through the Ontario Together Fund to help CHS modernize and expand its Oakville plant, build up Ontario’s domestic manufacturing capacity, and support emergency readiness while reportedly creating fifty new jobs.
“These acquisitions provide us with the ability to manufacture and supply a greater volume of Ontario-produced medical products for the Canadian and US markets and provide an alternative for healthcare customers to avoid some of the current challenges associated with sourcing products from overseas,” said Mike Canzoneri, president and CEO of CHS in a statement.
“The acquisitions also reinforce CHS’ continued commitment to make strategic investments in Ontario’s manufacturing infrastructure and personnel.”